首页> 外文期刊>Retina >Disposable eyelid speculum designed for intravitreal injection.
【24h】

Disposable eyelid speculum designed for intravitreal injection.

机译:专为玻璃体内注射而设计的一次性眼睑镜。

获取原文
获取原文并翻译 | 示例
           

摘要

Intravitreal drug injection has been increasing dramatically. The antivascular endothelial growth factor drugs, which are used as the firstline treatment for wet age-related macular degeneration, require repeated injections to maintain their effectiveness. The injections are usually administered in the office to avoid missing the best treatment interval. Endoph-thalmitis is rare, but it is a serious complication after intravitreal injection. The major cause is considered to be the bacterial contamination from the ocular surface, eyelids, or eyelashes via the injection needle. Meticulous draping of the eyelids may reduce the risk of endophthalmitis, but that is not realistic because of the large number of intravitreal injections administered. Actually, some cases of endophthalmitis were associated with the failure to use an eyelid speculum. We introduce a new disposable plastic eyelid speculum EzSpec (Hoya Corporation, Tokyo, Japan) with broader plates holding the eyelids to facilitate intravitreal injection.
机译:玻璃体内药物注射已经急剧增加。抗血管内皮生长因子药物被用作湿性年龄相关性黄斑变性的一线治疗药物,需要反复注射以维持其有效性。通常在办公室进行注射,以避免错过最佳治疗间隔。内咽炎很少见,但在玻璃体内注射后是严重的并发症。认为主要原因是通过注射针从眼表,眼睑或睫毛引起的细菌污染。眼睑的精细披覆可减少眼内炎的风险,但这是不现实的,因为进行了大量的玻璃体内注射。实际上,某些眼内炎病例与未能使用眼睑镜有关。我们推出了一种新型的一次性塑料眼睑镜EzSpec(日本,东京,Hoya公司),其具有可握住眼睑的更宽的板,以便于玻璃体内注射。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号